UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 31, 2022
Accession Number:
Submission Type:
CIK:
0001729427
Company Name:
CNS Pharmaceuticals, Inc.
File Number:
333-262262